» Articles » PMID: 15723048

Generation of High-affinity Human Antibodies by Combining Donor-derived and Synthetic Complementarity-determining-region Diversity

Abstract

Combinatorial libraries of rearranged hypervariable V(H) and V(L) sequences from nonimmunized human donors contain antigen specificities, including anti-self reactivities, created by random pairing of V(H)s and V(L)s. Somatic hypermutation of immunoglobulin genes, however, is critical in the generation of high-affinity antibodies in vivo and occurs only after immunization. Thus, in combinatorial phage display libraries from nonimmunized donors, high-affinity antibodies are rarely found. Lengthy in vitro affinity maturation is often needed to improve antibodies from such libraries. We report the construction of human Fab libraries having a unique combination of immunoglobulin sequences captured from human donors and synthetic diversity in key antigen contact sites in heavy-chain complementarity-determining regions 1 and 2. The success of this strategy is demonstrated by identifying many monovalent Fabs against multiple therapeutic targets that show higher affinities than approved therapeutic antibodies. This very often circumvents the need for affinity maturation, accelerating discovery of antibody drug candidates.

Citing Articles

A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema.

Sexton D, Faucette R, Rivera-Hernandez M, Kenniston J, Papaioannou N, Cosic J Front Allergy. 2024; 5:1436855.

PMID: 39391687 PMC: 11464748. DOI: 10.3389/falgy.2024.1436855.


MEDI1814 selectively reduces free Aβ42 in cerebrospinal fluid of non-clinical species and Alzheimer's disease patients.

Lloyd C, Freskgard P, Newton P, Lowne D, Nickson A, Bogstedt A Alzheimers Dement. 2024; 20(11):7762-7776.

PMID: 39319998 PMC: 11567870. DOI: 10.1002/alz.14238.


A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability.

Ferrara F, Fanni A, Teixeira A, Molina E, Leal-Lopes C, DeAguero A MAbs. 2024; 16(1):2394230.

PMID: 39192463 PMC: 11352698. DOI: 10.1080/19420862.2024.2394230.


De novo generation of SARS-CoV-2 antibody CDRH3 with a pre-trained generative large language model.

He H, He B, Guan L, Zhao Y, Jiang F, Chen G Nat Commun. 2024; 15(1):6867.

PMID: 39127753 PMC: 11316817. DOI: 10.1038/s41467-024-50903-y.


Development of a synthetic library of humanized nanobodies for targeted IL-6 inhibition.

Wang L, Dong J, Wu C, Yan C, Bi C, Xu C Front Bioeng Biotechnol. 2024; 12:1440150.

PMID: 39108599 PMC: 11300276. DOI: 10.3389/fbioe.2024.1440150.